$5250 | Single User
$6250 | Site License
$8450 | Enterprise License

Muckle-Wells Syndrome Market: By family of Cryopyrin (Associated periodic syndromes (CAPS), mutation of CIAS1 gene) & By Region-Forecast (2016-2021)
[Report Updated: 08-01-2016]

Published by Industry ARC: 08 Jan 2016 | 80371 | In Stock
Related Topics: Novartis

Introduction

Muckle-Wells Syndrome (MWS) is a rare, genetic autosomal disease which leads to urticaria, sensorineural deafness, and also leads to amyloidosis. The disease is mainly caused due to mutation of CIAS1 gene, that leads to increased production of interleukin 1B. Globally, Extensive R&D activities, Technological advancement in research and genetic sciences and Growing concern about various genetic disorders are the prime growth drivers of global Near Infrared Imaging market. In addition, increase in adoption of Muckle-Wells Syndrome for newer applications, will create new opportunities for global Near Infrared Imaging market. However, higher cost of the research and development, lack of awareness and Low epidemiology are the key restraints for global Near Infrared Imaging market.


Geographically North America dominated global Muckle-Wells Syndrome market, and Asia Pacific is projected to have fastest growth, owing to extensive R&D activities, technological advancement in research and genetic sciences and growing concern about various genetic disorders. Extensive R&D is one of the major factor, propelling the market growth. Among all the family of cryopyrin, associated periodic syndromes (CAPS) have the highest market share in global Muckle-Wells Syndrome market.

This report identifies the global Muckle-Wells Syndrome market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global Muckle-Wells Syndrome market.

This report segments global Muckle-Wells Syndrome market on the basis of family of Cryopyrin, and regional market as follows:

Muckle-Wells Syndrome Market, By family of Cryopyrin: Associated periodic syndromes (CAPS), mutation of CIAS1 gene and Others

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region. The major countries considered under the Asia-Pacific region are India, China, South Korea and Japan. The major countries considered under the European region are Germany, U.K., France, Italy, Spain and Russia. The major countries considered under the North American region are United States, Canada and Mexico

This report identifies all the major companies operating in the Muckle-Wells Syndrome market. Some of the major companies’ profiles in detail are as follows:

Novartis AG

Istituto Giannina Gaslini

Regeneron Pharmaceuticals, Inc.

Charite-Universitatsmedizin Berlin

Fresenius Medical Care.

Table of Contents
for Muckle-Wells Syndrome Market: By family of Cryopyrin (Associated periodic syndromes (CAPS), mutation of CIAS1 gene) & By Region-Forecast (2016-2021) [Report Updated: 08-01-2016]

  • 1. Muckle-Wells Syndrome Market – Market Overview

    2. Executive Summary

    3. Market Landscape

    3.1. Market Share Analysis

    3.2. Comparative Analysis

    3.3. Product Benchmarking

    3.4. End User Profiling

    3.5. Top 5 Financials Analysis

    4. Muckle-Wells Syndrome Market– Market Forces

    4.1. Drivers

    4.1.1. Technological advancement in research and genetic sciences

    4.1.2. Growing concern about various genetic disorders

    4.2. Restraints

    4.2.1. Low epidemiology

    4.2.2. High cost of R&D and treatment

    4.3. Opportunities

    4.3.1. Emerging economies

    4.3.2. Increase in adoption of Muckle-Wells Syndrome for newer applications

    4.4. Challenges

    4.5. Porter’s Five Forces Analysis

    4.5.1. Bargaining Power of Suppliers

    4.5.2. Bargaining Power of Buyers

    4.5.3. Threat of New Entrants

    4.5.4. Threat of Substitutes

    4.5.5. Degree of Competition

    5. Muckle-Wells Syndrome Market– Strategic Analysis

    5.1. Value Chain Analysis

    5.2. Pricing Analysis

    5.3. Opportunities Analysis

    5.4. Product/Market Life Cycle Analysis

    5.5. Suppliers and Distributors

    6. Muckle-Wells Syndrome Market, By family of Cryopyrin

    6.1. Associated periodic syndromes (CAPS)

    6.2. Mutation of CIAS1 gene Polyamide

    6.3. Others

    7. Muckle-Wells Syndrome Market, By Geography

    7.1. Europe

    7.1.1. Germany

    7.1.2. France

    7.1.3. Italy

    7.1.4. Spain

    7.1.5. Russia

    7.1.6. U.K.

    7.1.7. Rest of Europe

    7.2. Asia Pacific

    7.2.1. China

    7.2.2. India

    7.2.3. Japan

    7.2.4. South Korea

    7.2.5. Rest of Asia-Pacific

    7.3. North America

    7.3.1. U.S.

    7.3.2. Canada

    7.3.3. Mexico

    7.4. Rest of the World (RoW)

    7.4.1. Brazil

    7.4.2. Rest of RoW

    8. Muckle-Wells Syndrome – Market Entropy

    8.1. Expansion

    8.2. Technological Developments

    8.3. Merger & Acquisitions, and Joint Ventures

    8.4. Supply- Contract

    9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

    9.1. Novartis AG

    9.2. Istituto Giannina Gaslini

    9.3. Regeneron Pharmaceuticals, Inc.

    9.4. Charite-Universitatsmedizin Berlin

    9.5. Fresenius Medical Care

    9.6. Huaren Pharmaceutical

    9.7. Medical Components

    9.8. Medical Components

    9.9. NephroPlus

    9.10. Nipro

    *More than 40 Companies are profiled in this Research Report, Complete List available on Request*

    "*Financials would be provided on a best efforts basis for private companies"

    10. Appendix

    10.1. Abbreviations

    10.2. Sources

    10.3. Research Methodology

    10.4. Bibliography

    10.5. Compilation of Expert Insights

    10.6. Disclaimer

List Of Tables
in Muckle-Wells Syndrome Market: By family of Cryopyrin (Associated periodic syndromes (CAPS), mutation of CIAS1 gene) & By Region-Forecast (2016-2021) [Report Updated: 08-01-2016]

No

Additional Details

Publisher

Industry ARC

Publisher Information

IndustryARC is the Leading Provider of Market Research Reports, Custom Consulting Services, Data Analytics and Industry Analysis. Our goal is to provide the right information required by the stakeholder at the right point of time, in a format which assists an intelligent and informed decision making process!



We provide profound information with a proactive collaboration with the clients to identify new opportunities and guide them to find the best strategy for finding growth avenues. Our in-depth Research Reports with analysis done by experienced consultants and inputs from industry experts, Key Opinion Leaders (KOLs) span multiple sectors such as:

Reference

80371 | HCR 0294

Report Format

PDF

Industry ARC Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2016
Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial repo...
31 Aug 2016 by Global Data USD $2,500 More Info

This report is published by Industry ARC

IndustryARC is the Leading Provider of Market Research Reports, Custom Consulting Services, Data Analytics and Industry Analysis. Our goal is to provide the right information required by the stakeholder at the right point of time, in a format which assists an intelligent and informed decision making process!

We provide profound information with a proactive collaboration with the clients to identify new opportunities and guide them to find the best strategy for finding growth avenues. Our in-depth Research Reports with analysis done by experienced consultants and inputs from industry experts, Key Opinion Leaders (KOLs) span multiple sectors such as:

Download Free Report Summary PDF

Muckle-Wells Syndrome Market: By family of Cryopyrin (Associated periodic syndromes (CAPS), mutation of CIAS1 gene) & By Region-Forecast (2016-2021) [Report Updated: 08-01-2016] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)